pharmaphorum

SEPTEMBER 2, 2021

An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national surveillance system. The decision support system (DSS) – developed by Italian digital health startup Paginemediche – provided a way for people to assess and interpret their symptoms and provide guidance on what to do next, such as self-isolate or seek out a test.

Hospitals 138

Hospitals 138

NY Times

AUGUST 30, 2021

Prescriptions for ivermectin have jumped to more than 88,000 per week, some pharmacists are reporting shortages and people are overdosing on forms of the drug meant for horses.

122

122

Outsourcing Pharma

AUGUST 30, 2021

A leader from the rare and infectious disease treatment specialist talks about ongoing research into a potential treatment for mild-to-moderate COVID-19.

131

131

Drug Patent Watch

AUGUST 30, 2021

Annual Drug Patent Expirations for NAPROXEN+SODIUM Naproxen Sodium is a drug marketed by Bionpharma Inc, Catalent, Puracap Pharm Llc, Actavis Labs Fl Inc, Able, Amneal Pharms Ny, Aurobindo Pharma Ltd,…. The post New patent for Bionpharma Inc drug NAPROXEN SODIUM appeared first on DrugPatentWatch - Make Better Decisions.

88

88

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 31, 2021

Fitness wearable company Whoop has raised another $200 million in funding that will help fund its expansion into international markets – and take on deep-pocketed rivals like Amazon, Apple and Google. The sixth-round financing was led by SoftBank’s Vision Fund 2, taking the total raised by the company to date to around $400 million, and catapults Whoop’s valuation to a massive $3.6 billion.

127

127

NY Times

SEPTEMBER 1, 2021

The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.

118

118

Pharma Times

SEPTEMBER 1, 2021

Agreement will allow NICE to make ‘efficient and effective’ updates to recommendations in its guideline portfolio

97

97

pharmaphorum

SEPTEMBER 1, 2021

An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost 3 million patients and previously found to be more effective than existing testing at identifying patients at risk of AF based on retrospective stud

126

126

NY Times

SEPTEMBER 1, 2021

“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series of shows in Florida.

Vaccines 105

Vaccines Immunity Immunization 105

Outsourcing Pharma

SEPTEMBER 2, 2021

The decentralized trial tech firm will work with Applied VR on five studies testing the viability of virtual-reality therapy in treating pain patients.

103

103

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

AUGUST 31, 2021

Phase III trial will use AZ’s COVID-19 vaccine as an active comparator

Vaccines 113

Vaccines 113

pharmaphorum

SEPTEMBER 2, 2021

A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners. The agreement will dissolve the OxyContin (oxycodone) manufacturer – which Judge Robert Drain said was a “bitter result” – will see around $4.5 billion being paid out by the Sackler family to projects that support victims of the o

Immunity 96

Immunity Immunization 96

NY Times

AUGUST 31, 2021

The deaths over three days in Suffolk County reflect a dangerous shift in the street-drug marketplace, according to police and prosecutors.

99

99

Outsourcing Pharma

AUGUST 30, 2021

FarmaTrust is helping assemble a collective of public and private firms working on solutions for smart manufacturing and creating medicines of the future.

102

102

Pharma Times

SEPTEMBER 3, 2021

The monoclonal antibody is designed to block IL-17A, a molecule involved in the psoriasis inflammatory response

93

93

pharmaphorum

SEPTEMBER 1, 2021

Novartis’ cholesterol-lowering drug Leqvio will be made available on the NHS in England and Wales, and could help to prevent up to 30,000 deaths, according to NICE. The PCSK9-targeting oligonucleotide – which is already available in Scotland – requires dosing just twice a year and has been approved by the health technology assessment (HTA) agency for use in people with atherosclerotic cardiovascular disease (ASCVD) who can’t reach target cholesterol levels with oral statins alone.

94

94

NY Times

AUGUST 31, 2021

The deaths over three days in Suffolk County reflect a dangerous shift in the street-drug marketplace, according to police and prosecutors.

95

95

Drug Channels

AUGUST 31, 2021

Charlotte Morabito at CNBC has put together “Why Pharmacies Overcharge,” an entertaining and provocative video on the pharmacy industry and its generic prescription pricing. It’s definitely worth your time. I especially enjoyed the cool visualizations of Drug Channels Institute’s industry data. Links below. The video covers the history of pharmacy, from the “Soda Fountain Era” to “Lick, Stick, and Pour” to the rise of PBMs and GoodRx. .

71

71

Pharma Times

AUGUST 31, 2021

Metastatic triple-negative breast cancer treatment failed to meet PFS primary endpoint

105

105

pharmaphorum

SEPTEMBER 1, 2021

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered. The publication, which has been supported by Accord Healthcare, also provides a series of recommendations for how the pharmaceutical industry can continue to support cancer care for the next 12 months and looks at what physicians want

88

88

NY Times

AUGUST 31, 2021

Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.

Vaccines 98

Vaccines Immunity Immunization 98

Outsourcing Pharma

SEPTEMBER 1, 2021

Johnson & Johnson has announced results from the primary analysis of its Imbokodo Phase 2b HIV vaccine clinical trial, with data showing the investigational HIV vaccine candidate did not provide sufficient protection against HIV infection. A Phase 3 trial with a different composition of the vaccine regimen and different populations, however, will continue.

Vaccines 64

Vaccines 64

Pharma Times

SEPTEMBER 3, 2021

Samedan joining PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division

87

87

pharmaphorum

SEPTEMBER 1, 2021

One of the biggest challenges to treating schizophrenia is non-compliance with treatment, but Johnson & Johnson’s pharma unit Janssen is trumpeting a new version of its Invega drug that could solve that problem. The FDA has just approved Janssen’s Invega Hafyera (paliperidone), a twice-yearly injectable formulation that extends the company’s big-selling brand and offers the fewest doses per year of any schizophrenia medicine.

87

87

NY Times

AUGUST 30, 2021

As children's hospital beds fill up, the F.D.A. shouldn't delay. .

Vaccines 89

Vaccines Hospitals Immunity Immunization 89

Outsourcing Pharma

AUGUST 31, 2021

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

67

67

Pharma Times

SEPTEMBER 1, 2021

Phase III study finds risk reduced by 52% compared with control group

104

104

pharmaphorum

SEPTEMBER 1, 2021

Astellas has halted dosing in a study of its AT132 gene therapy for the rare disease X-linked myotubular myopathy (XLMTM) for the second time after another serious adverse event (SAE) linked to possible liver damage. The ASPIRO trial of AT132 has been paused after abnormal liver function tests (LFTs) were seen in a patient receiving the gene therapy, and information on the adverse event has been shared with regulators, according to the drugmaker.

78

78

NY Times

AUGUST 30, 2021

As children's hospital beds fill up, the F.D.A. shouldn't delay. .

Vaccines 87

Vaccines Hospitals Immunity Immunization 87

Outsourcing Pharma

AUGUST 31, 2021

Cota has released a survey revealing about two-thirds of cancer patients and their families are unsatisfied at the speed of cancer treatment development.

60

60

Pharma Times

SEPTEMBER 3, 2021

Trial showed ‘robust antibody responses’ against Delta variant

Vaccines 98

Vaccines 98

pharmaphorum

AUGUST 31, 2021

For the healthcare ecosystem to drive research and care, clarity is needed about the opportunities and challenges of ECAs and their value in bringing therapies to patients faster, say COTA Viraj Narayanan and Karla Feghali from ConvergeHEALTH by Deloitte. External control arms (ECAs) – also known as synthetic control arms – are based on real world data (RWD) pulled from electronic health records, medical claims, wearable devices and other sources of patient data.

Insurance Coverage and Processing 66

Insurance Coverage and Processing Drug Development Documentation Labelling 66

Drug Patent Watch

SEPTEMBER 3, 2021

Annual Drug Patent Expirations for QUILLICHEW+ER Quillichew Er is a drug marketed by Nextwave Pharms and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent for Nextwave Pharms drug QUILLICHEW ER appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Mirror

SEPTEMBER 2, 2021

Frankfurt/Hyderabad, DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s status as a major pharma production and export hub. With the new location in India, DoKaSch strengthens its network in the region and globally.

52

52

Pharma Times

SEPTEMBER 1, 2021

Large-scale phase III study met all primary and secondary endpoints

99

99